UY27024A1 - METHODS OF TREATMENT OF CONDITIONS ASSOCIATED WITH CINASE P38 AND PIRROLOTRIAZINE COMPOUNDS USEFUL AS CINASE INHIBITORS - Google Patents

METHODS OF TREATMENT OF CONDITIONS ASSOCIATED WITH CINASE P38 AND PIRROLOTRIAZINE COMPOUNDS USEFUL AS CINASE INHIBITORS

Info

Publication number
UY27024A1
UY27024A1 UY27024A UY27024A UY27024A1 UY 27024 A1 UY27024 A1 UY 27024A1 UY 27024 A UY27024 A UY 27024A UY 27024 A UY27024 A UY 27024A UY 27024 A1 UY27024 A1 UY 27024A1
Authority
UY
Uruguay
Prior art keywords
cinase
methods
conditions associated
pirrolotriazine
treatment
Prior art date
Application number
UY27024A
Other languages
Spanish (es)
Inventor
Katerina Leftheris
Joel Barrish
John Hynes
Stephen T Wrobleski
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of UY27024A1 publication Critical patent/UY27024A1/en

Links

Abstract

Se describen los métodos de tratamiento de una o más condiciones asociadas con la actividad de la cinasa p38 que comprenden el administrarle a un paciente en necesidad del mismo al menos un compuesto que tiene la fórmula (I); o una sal, pro fármaco o solvato farmacéuticamente aceptable del mismo, en donde R3 es hidrógeno, metil, perfluorometilo, metoxi, halógeno, ciano, o NH2, preferentemente metilo, y X, R1 a R6 y Z son como se describen en la especificación. Ventajosamente, los grupos -ZR4R5 tomados conjuntamente comprenden arilo sustituido con -NH.Methods of treating one or more conditions associated with the activity of p38 kinase are described, which comprise administering to a patient in need thereof at least one compound having the formula (I); or a pharmaceutically acceptable salt, pro-drug or solvate thereof, wherein R3 is hydrogen, methyl, perfluoromethyl, methoxy, halogen, cyano, or NH2, preferably methyl, and X, R1 to R6 and Z are as described in the specification . Advantageously, the -ZR4R5 groups taken together comprise aryl substituted with -NH.

UY27024A 2001-08-07 2001-11-15 METHODS OF TREATMENT OF CONDITIONS ASSOCIATED WITH CINASE P38 AND PIRROLOTRIAZINE COMPOUNDS USEFUL AS CINASE INHIBITORS UY27024A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31056101P 2001-08-07 2001-08-07

Publications (1)

Publication Number Publication Date
UY27024A1 true UY27024A1 (en) 2002-07-31

Family

ID=35518860

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27024A UY27024A1 (en) 2001-08-07 2001-11-15 METHODS OF TREATMENT OF CONDITIONS ASSOCIATED WITH CINASE P38 AND PIRROLOTRIAZINE COMPOUNDS USEFUL AS CINASE INHIBITORS

Country Status (2)

Country Link
UA (1) UA74024C2 (en)
UY (1) UY27024A1 (en)

Also Published As

Publication number Publication date
UA74024C2 (en) 2005-10-17

Similar Documents

Publication Publication Date Title
YU37903A (en) Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
PA8501801A1 (en) TRIMYCLY POLYMERASE INHIBITORS (ADP - POLIRRIBOSAS)
AR029216A1 (en) NON-PEPTIDIC INHIBITING COMPOUNDS OF THE VLA-4 DEPENDENT CELL UNION IN THE TREATMENT OF INFLAMMATORY, AUTOIMMUNE AND RESPIRATORY DISEASES; PHARMACEUTICAL COMPOSITION AND TREATMENT PROCEDURE
ECSP044992A (en) INHIBITORS OF THE ALQUÍN-ARIL FOSFODIESTERASA-4
PA8504401A1 (en) PHARMACEUTICALLY ACTIVE COMPOUNDS
CO5700752A2 (en) PIPERAZINE AND PIPERAZIN-2-ONA SPECIFIC DERIVATIVES TO THE MELANO CURTAIN RECEIVER
UY29246A1 (en) NEW COMPOUNDS
NO20060664L (en) N-substituted benzimidazolyl C-kit inhibitors
CY1106679T1 (en) AZADICYCLIC HETEROCYCLIC COMPOUNDS AS CANNABINOID RECEPTOR MODIFIERS
HUP0105414A2 (en) Pyrrolo-isoquinoline, azepino- and diazepino-indole derivatives, their use and pharmaceutical compisitions containing them
ECSP055864A (en) REPLACED DERIVATIVES OF PIRROLO-PIRAZOL AS INHIBITORS OF QUINASA
ECSP034642A (en) DERIVATIVES OF TETRALONA AS ANTITUMOR AGENTS
CO5590894A2 (en) DERIVATIVES OF A- (N-SULFONAMIDE) ACETAMIDE AS INHIBITORS OF THE B-AMYLOID PEPTIDE
GT200000002A (en) UREAS DIFENILICIAS X - CARBOXYARIL REPLACED AS RAF KINASE INHIBITORS.
NO20055655L (en) Use of azetidinecarboxamide derivatives in therapy
TR200201505T2 (en) Pirazolopyrimidines as therapeutic agents
YU49443B (en) Benzimidazole derivatives, processes for their preparation, and their use in medical therapy, particulary for treating or preventing viral infections
EA200401167A1 (en) DERIVATIVES OF TROPANE AS CCR5 MODULATORS
ECSP088484A (en) SPIROCYCLIC QUINAZOLINE DERIVATIVES AS PDE7 INHIBITORS
UY28255A1 (en) DOSAGE FORMS AND TREATMENT PROCEDURES USING VEGER INHIBITORS
ES2180933T3 (en) INHIBITOR OF SERINA-PROTEASA.
UY27024A1 (en) METHODS OF TREATMENT OF CONDITIONS ASSOCIATED WITH CINASE P38 AND PIRROLOTRIAZINE COMPOUNDS USEFUL AS CINASE INHIBITORS
ATE246174T1 (en) TOSYLPROLINE DERIVATIVES AS THYMIDYLATE SYNTHASE INHIBITORS
AR027035A1 (en) PIRROLES REPLACED
PT1059845E (en) FUNGICIDE COMPOSITION UNDERSTANDING A BENZOYLPHENYLURIA

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20141105